Investor Alert

New York Markets Open in:

Johnson & Johnson

NYS: JNJ

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Feb 25, 2021, 9:15 a.m.

JNJ
/zigman2/quotes/201724570/composite

$

163.93

Change

+1.34 +0.82%

Volume

Volume 80,130

Real time quotes

/zigman2/quotes/201724570/composite

Previous close

$ 162.59

$ 162.59

Change

+2.15 +1.34%

Day low

Day high

$160.92

$164.39

Open

52 week low

52 week high

$109.16

$173.65

Open

Company Description

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, o...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Valuation

P/E Current

29.12

P/E Ratio (with extraordinary items)

29.10

P/E Ratio (without extraordinary items)

27.98

Price to Sales Ratio

4.98

Efficiency

Liquidity

Cash Ratio

0.59

Profitability

Gross Margin

71.22

Operating Margin

24.11

Pretax Margin

19.98

Net Margin

17.82

Capital Structure

Officers and Executives

Name Age Officer Since Title
Mr. Alex Gorsky 58 2008 Member-Executive Committee
Mr. Joseph J. Wolk - 2016 Vice President-Investor Relations
Mr. James D. Swanson - 2019 Global Chief Information Officer & Executive VP
Dr. Paulus Stoffels 58 - Chairman-Worldwide Pharmaceuticals Group
Dr. Mathai Mammen 52 2017 Head-Science & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/12/2021 Alex Gorsky
Chairman, CEO; Director
27,393   Derivative/Non-derivative trans. at $165.55 per share. 4,534,911
02/12/2021 Alex Gorsky
Chairman, CEO; Director
4,313   Derivative/Non-derivative trans. at $165.55 per share. 714,017
02/12/2021 Paulus Stoffels
Vice Chair, Exec Committee
12,725   Derivative/Non-derivative trans. at $165.55 per share. 2,106,623
02/12/2021 Paulus Stoffels
Vice Chair, Exec Committee
1,592   Derivative/Non-derivative trans. at $165.55 per share. 263,555
02/12/2021 Joaquin Duato
Vice Chair, Exec Committee
11,931   Derivative/Non-derivative trans. at $165.55 per share. 1,975,177
02/12/2021 Joaquin Duato
Vice Chair, Exec Committee
1,507   Derivative/Non-derivative trans. at $165.55 per share. 249,483
02/12/2021 Michael H. Ullmann
Exec VP, General Counsel
5,648   Derivative/Non-derivative trans. at $165.55 per share. 935,026
02/12/2021 Michael H. Ullmann
Exec VP, General Counsel
846   Derivative/Non-derivative trans. at $165.55 per share. 140,055
02/12/2021 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
5,268   Derivative/Non-derivative trans. at $165.55 per share. 872,117
02/12/2021 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
797   Derivative/Non-derivative trans. at $165.55 per share. 131,943
02/12/2021 Peter M. Fasolo
Exec VP, Chief HR Officer
4,935   Derivative/Non-derivative trans. at $165.55 per share. 816,989
02/12/2021 Peter M. Fasolo
Exec VP, Chief HR Officer
761   Derivative/Non-derivative trans. at $165.55 per share. 125,983
02/12/2021 Michael E. Sneed
EVP, Global Corp Aff & CCO
2,676   Derivative/Non-derivative trans. at $165.55 per share. 443,011
02/12/2021 Michael E. Sneed
EVP, Global Corp Aff & CCO
437   Derivative/Non-derivative trans. at $165.55 per share. 72,345
02/12/2021 Kathryn E Wengel
EVP, Chief GSC Officer
3,796   Derivative/Non-derivative trans. at $165.55 per share. 628,427
02/12/2021 Kathryn E Wengel
EVP, Chief GSC Officer
618   Derivative/Non-derivative trans. at $165.55 per share. 102,309
02/12/2021 Thibaut Mongon
Exec VP, WW Chair, Consumer
1,950   Derivative/Non-derivative trans. at $165.55 per share. 322,822
02/12/2021 Thibaut Mongon
Exec VP, WW Chair, Consumer
1,425   Derivative/Non-derivative trans. at $165.55 per share. 235,908
02/12/2021 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
4,090   Derivative/Non-derivative trans. at $165.55 per share. 677,099
02/12/2021 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
588   Derivative/Non-derivative trans. at $165.55 per share. 97,343
02/12/2021 Joseph J. Wolk
Exec VP, CFO
733   Derivative/Non-derivative trans. at $165.55 per share. 121,348
02/12/2021 Joseph J. Wolk
Exec VP, CFO
723   Derivative/Non-derivative trans. at $165.55 per share. 119,692
02/12/2021 Robert J. Decker
Controller, CAO
261   Derivative/Non-derivative trans. at $165.55 per share. 43,208
02/12/2021 Robert J. Decker
Controller, CAO
225   Derivative/Non-derivative trans. at $165.55 per share. 37,248
02/12/2021 Alex Gorsky
Chairman, CEO; Director
12,017   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Alex Gorsky
Chairman, CEO; Director
63,088   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Paulus Stoffels
Vice Chair, Exec Committee
5,610   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Paulus Stoffels
Vice Chair, Exec Committee
29,452   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Joaquin Duato
Vice Chair, Exec Committee
5,283   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Joaquin Duato
Vice Chair, Exec Committee
27,738   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Michael H. Ullmann
Exec VP, General Counsel
2,311   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Michael H. Ullmann
Exec VP, General Counsel
12,133   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
2,177   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
11,429   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Peter M. Fasolo
Exec VP, Chief HR Officer
2,060   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Peter M. Fasolo
Exec VP, Chief HR Officer
10,813   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Michael E. Sneed
EVP, Global Corp Aff & CCO
1,474   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Michael E. Sneed
EVP, Global Corp Aff & CCO
7,737   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Kathryn E Wengel
EVP, Chief GSC Officer
1,658   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Kathryn E Wengel
EVP, Chief GSC Officer
8,704   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Thibaut Mongon
Exec VP, WW Chair, Consumer
3,572   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Thibaut Mongon
Exec VP, WW Chair, Consumer
3,573   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
2,102   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
11,034   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Joseph J. Wolk
Exec VP, CFO
2,543   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Joseph J. Wolk
Exec VP, CFO
2,543   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Robert J. Decker
Controller, CAO
655   Derivative/Non-derivative trans. at $0 per share. 0
02/12/2021 Robert J. Decker
Controller, CAO
655   Derivative/Non-derivative trans. at $0 per share. 0
12/09/2020 Michael E. Sneed
EVP, Global Corp Aff & CCO
54,662   Disposition at $152.93 per share. 8,359,459
12/09/2020 Michael E. Sneed
EVP, Global Corp Aff & CCO
54,662   Derivative/Non-derivative trans. at $62.2 per share. 3,399,976
11/25/2020 Alex Gorsky
Chairman, CEO; Director
13,960   Gift at $0 per share. 0
11/25/2020 Alex Gorsky
Chairman, CEO; Director
6,990   Gift at $0 per share. 0
09/14/2020 Alex Gorsky
Chairman, CEO; Director
2,750   0
09/02/2020 Kathryn E Wengel
EVP, Chief GSC Officer
8,238   Disposition at $153.53 per share. 1,264,780
09/02/2020 Kathryn E Wengel
EVP, Chief GSC Officer
7,877   Disposition at $153.51 per share. 1,209,198
09/02/2020 Kathryn E Wengel
EVP, Chief GSC Officer
7,877   Derivative/Non-derivative trans. at $65.37 per share. 514,919
09/02/2020 Kathryn E Wengel
EVP, Chief GSC Officer
8,238   Derivative/Non-derivative trans. at $62.2 per share. 512,403
07/28/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
29,000   Disposition at $147.47 per share. 4,276,630
03/13/2020 William David Perez
Director
500   Acquisition at $127.69 per share. 63,845
02/21/2020 Thibaut Mongon
Exec VP, WW Chair, Consumer
39,224   Disposition at $147.96 per share. 5,803,583
02/21/2020 Thibaut Mongon
Exec VP, WW Chair, Consumer
19,224   Derivative/Non-derivative trans. at $90.44 per share. 1,738,618
02/13/2020 Alex Gorsky
Chairman, CEO; Director
32,668   Derivative/Non-derivative trans. at $150.46 per share. 4,915,227
02/13/2020 Alex Gorsky
Chairman, CEO; Director
12,803   Derivative/Non-derivative trans. at $150.46 per share. 1,926,339
02/13/2020 Paulus Stoffels
Vice Chair, Exec Committee
12,022   Derivative/Non-derivative trans. at $150.46 per share. 1,808,830
02/13/2020 Paulus Stoffels
Vice Chair, Exec Committee
4,079   Derivative/Non-derivative trans. at $150.46 per share. 613,726
02/13/2020 Joaquin Duato
Vice Chair, Exec Committee
29,721   Derivative/Non-derivative trans. at $150.46 per share. 4,471,821
02/13/2020 Joaquin Duato
Vice Chair, Exec Committee
10,670   Derivative/Non-derivative trans. at $150.46 per share. 1,605,408
02/13/2020 Joaquin Duato
Vice Chair, Exec Committee
3,513   Derivative/Non-derivative trans. at $150.46 per share. 528,565
02/13/2020 Michael H. Ullmann
Exec VP, General Counsel
7,219   Derivative/Non-derivative trans. at $150.46 per share. 1,086,170
02/13/2020 Michael H. Ullmann
Exec VP, General Counsel
2,194   Derivative/Non-derivative trans. at $150.46 per share. 330,109
02/13/2020 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
4,277   Derivative/Non-derivative trans. at $150.46 per share. 643,517
02/13/2020 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
3,951   Derivative/Non-derivative trans. at $150.46 per share. 594,467
02/13/2020 Peter M. Fasolo
Exec VP, Chief HR Officer
7,989   Derivative/Non-derivative trans. at $150.46 per share. 1,202,024
02/13/2020 Peter M. Fasolo
Exec VP, Chief HR Officer
2,404   Derivative/Non-derivative trans. at $150.46 per share. 361,705
02/13/2020 Michael E. Sneed
EVP, Global Corp Aff & CCO
2,672   Derivative/Non-derivative trans. at $150.46 per share. 402,029
02/13/2020 Michael E. Sneed
EVP, Global Corp Aff & CCO
2,468   Derivative/Non-derivative trans. at $150.46 per share. 371,335
02/13/2020 Kathryn E Wengel
EVP, Chief GSC Officer
4,203   Derivative/Non-derivative trans. at $150.46 per share. 632,383
02/13/2020 Kathryn E Wengel
EVP, Chief GSC Officer
2,909   Derivative/Non-derivative trans. at $150.46 per share. 437,688
02/13/2020 Thibaut Mongon
Exec VP, WW Chair, Consumer
750   Derivative/Non-derivative trans. at $150.46 per share. 112,845
02/13/2020 Thibaut Mongon
Exec VP, WW Chair, Consumer
694   Derivative/Non-derivative trans. at $150.46 per share. 104,419
02/13/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
3,031   Derivative/Non-derivative trans. at $150.46 per share. 456,044
02/13/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
2,801   Derivative/Non-derivative trans. at $150.46 per share. 421,438
02/13/2020 Joseph J. Wolk
Exec VP, CFO
1,112   Derivative/Non-derivative trans. at $150.46 per share. 167,311
02/13/2020 Joseph J. Wolk
Exec VP, CFO
979   Derivative/Non-derivative trans. at $150.46 per share. 147,300
02/13/2020 Robert J. Decker
Controller, CAO
285   Derivative/Non-derivative trans. at $150.46 per share. 42,881
02/13/2020 Robert J. Decker
Controller, CAO
270   Derivative/Non-derivative trans. at $150.46 per share. 40,624
02/13/2020 Alex Gorsky
Chairman, CEO; Director
31,779   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Alex Gorsky
Chairman, CEO; Director
75,237   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Paulus Stoffels
Vice Chair, Exec Committee
11,695   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Paulus Stoffels
Vice Chair, Exec Committee
27,686   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Joaquin Duato
Vice Chair, Exec Committee
10,374   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Joaquin Duato
Vice Chair, Exec Committee
24,561   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Joaquin Duato
Vice Chair, Exec Committee
70,733   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Michael H. Ullmann
Exec VP, General Counsel
6,036   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Michael H. Ullmann
Exec VP, General Counsel
14,290   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
7,724   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
8,360   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Peter M. Fasolo
Exec VP, Chief HR Officer
6,602   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Peter M. Fasolo
Exec VP, Chief HR Officer
15,629   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Michael E. Sneed
EVP, Global Corp Aff & CCO
5,684   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Michael E. Sneed
EVP, Global Corp Aff & CCO
6,152   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Kathryn E Wengel
EVP, Chief GSC Officer
7,592   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Kathryn E Wengel
EVP, Chief GSC Officer
8,217   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Thibaut Mongon
Exec VP, WW Chair, Consumer
1,773   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Thibaut Mongon
Exec VP, WW Chair, Consumer
1,919   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
6,602   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
7,145   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Joseph J. Wolk
Exec VP, CFO
3,400   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Joseph J. Wolk
Exec VP, CFO
3,680   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Robert J. Decker
Controller, CAO
720   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Robert J. Decker
Controller, CAO
779   Derivative/Non-derivative trans. at $0 per share. 0
02/03/2020 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
23,721   Derivative/Non-derivative trans. at $149.32 per share. 3,542,019
02/03/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
15,405   Derivative/Non-derivative trans. at $149.32 per share. 2,300,274
02/03/2020 Jennifer Taubert
EVP, WW Chair, Pharmaceuticals
48,312   Derivative/Non-derivative trans. at $0 per share. 0
02/03/2020 Ashley A. McEvoy
EVP, WW Chair, Medical Devices
38,650   Derivative/Non-derivative trans. at $0 per share. 0
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Dow futures flat and broader market set to slump after jobless claims report

    18 min ago

    - William Watts

  2. The Meme Trade Is Back

    8:13 a.m. Today

  3. Dow Hits Record High After Powell Testifies Again

    4:43 p.m. Feb. 24, 2021

    - Teresa Rivas

  4. The Market Is Falling Because Treasury Yields Won’t Stop Rising

    10:02 a.m. Feb. 24, 2021

    - Jacob Sonenshine

  5. FDA Brings J&J Vaccine a Step Closer to Authorization

    9:55 a.m. Feb. 24, 2021

    - Josh Nathan-Kazis

  6. Square Drops, TJX Slides as Market Rises on Vaccine Optimism

    8:53 a.m. Feb. 24, 2021

    - Jacob Sonenshine

  7. Loading more headlines...
/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. Wall Street Breakfast: GameStop Comeback

    7:16 a.m. Today

    - Seeking Alpha

  2. Pfizer, BioNTech Studying Third Covid-19 Vaccine Dose

    6:45 a.m. Today

    - Jared S. Hopkins

  3. 7 Blue-Chip Stocks to Buy as Dow Touches a New Milestone

    6:22 a.m. Today

    - Zacks.com

  4. Moderna Says New Variant Vaccine Is Ready for Human Testing

    7:18 p.m. Feb. 24, 2021

    - Peter Loftus

  5. Moderna: Expect Bad News Thursday

    6:30 p.m. Feb. 24, 2021

    - Seeking Alpha

  6. J&J’s Covid-19 Vaccine Is Safe and Effective, FDA Says

    5:51 p.m. Feb. 24, 2021

    - Thomas M. Burton

  7. ABNB Stock: Why Airbnb Is Booking Big Gains Today

    2:57 p.m. Feb. 24, 2021

    - InvestorPlace.com

  8. How to Create a Stock Portfolio

    12:58 p.m. Feb. 24, 2021

    - Zacks.com

  9. Airline Stocks: 2 Big Reasons AAL, DAL and UAL Stock Are Soaring Today

    12:52 p.m. Feb. 24, 2021

    - InvestorPlace.com

  10. Ghana Is First Nation to Get Free Covid-19 Vaccines Under Covax Plan

    12:49 p.m. Feb. 24, 2021

    - Gabriele Steinhauser

  11. J&J Vaccine Looks Ready for EUA; Lowe's (LOW) Beats in Q4

    10:10 a.m. Feb. 24, 2021

    - Zacks.com

  12. What Will the Stock Market Do Today? 4 Big Stories to Watch.

    10:03 a.m. Feb. 24, 2021

    - InvestorPlace.com

  13. Loading more headlines...

At a Glance

Johnson & Johnson

One Johnson & Johnson Plaza

New Brunswick, New Jersey 08933

Phone

1 7325240400

Industry

Pharmaceuticals

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2021

Revenue

$82.58B

Net Income

$14.71B

2020 Sales Growth

0.6%

Employees

-

/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Are These Top Health Care Stocks Worth Watching Ahead Of March?

    1 min ago

    - StockMarket.com

  2. 4 Top Health Care Stocks To Watch This Week

    4:08 p.m. Feb. 24, 2021

    - StockMarket.com

  3. Johnson & Johnson's COVID Approved for Emergency Use

    10:00 a.m. Feb. 24, 2021

    - Baystreet.ca

  4. Ongoing Public Mental Health Crisis Calls For Innovative Treatments

    8:52 a.m. Feb. 18, 2021

    - Financial News Media

  5. Ongoing Public Mental Health Crisis Calls For Innovative Treatments

    8:50 a.m. Feb. 18, 2021

    - PR Newswire - PRF

  6. How to trade Johnson & Johnson $JNJ With Risk Controls

    3:31 p.m. Feb. 13, 2021

    - Stock Traders Daily

  7. Loading more headlines...
Link to MarketWatch's Slice.